John Gallagher Sells 3,604 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 3,604 shares of the stock in a transaction on Friday, August 28th. The stock was sold at an average price of $29.70, for a total value of $107,038.80. Following the transaction, the chief operating officer owned 33,742 shares of the company’s stock, valued at approximately $1,002,137.40. This represents a 9.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Stock Up 1.4%

Shares of TRUP opened at $28.26 on Thursday. The firm has a market cap of $1.24 billion, a P/E ratio of 53.32, a price-to-earnings-growth ratio of 1.88 and a beta of 1.45. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98. The company’s 50-day moving average price is $27.30 and its 200 day moving average price is $25.86. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The company had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. Trupanion’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.22 earnings per share. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on TRUP. Weiss Ratings raised shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, August 26th. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday, July 15th. Piper Sandler cut Trupanion from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Finally, Stifel Nicolaus boosted their price objective on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $39.20.

Institutional Investors Weigh In On Trupanion

A number of hedge funds have recently added to or reduced their stakes in the business. Kelleher Financial Advisors acquired a new position in shares of Trupanion in the second quarter worth $42,000. Parallel Advisors LLC boosted its position in shares of Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the period. Kemnay Advisory Services Inc. acquired a new stake in shares of Trupanion in the fourth quarter valued at approximately $64,000. Quantbot Technologies LP purchased a new position in Trupanion during the 2nd quarter worth $89,000. Finally, Advisory Services Network LLC purchased a new position in shares of Trupanion during the third quarter worth about $160,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.